Gemini Bio to Distribute Scinus Products in the United States
* Gemini Bio adds Scinus Bioreactor to its portfolio
WEST SACRAMENTO, CA, and BILTHOVEN, The Netherlands, August 18, 2020 – Gemini Bioproducts, LLC (“Gemini Bio”), a leading supplier of cell culture solutions and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced a distribution agreement with Scinus Cell Expansion Netherlands BV (“Scinus”). Customers will now be able to purchase the Scinus Cell expansion bioreactor system directly from Gemini Bio in the US.
This cell expansion bioreactor system enables clinical scale stem cell cultivation in a controlled environment, which is a cost-effective alternative to traditional 2D cell growth in tissue culture flasks or cell stacks. The system contains a single use bioreactor bag that can be used to cultivate cells to clinically relevant numbers which can enable cutting edge cell therapies to be delivered to patients.
Brendan Lucey, Gemini Bio VP of Business Development, stated, “I am extremely excited to add Scinus’ innovative Bioreactor to the Gemini portfolio. In addition to supplying reagents and instruments for cell Quality Control, we now have a next generation bioreactor for cell therapy applications. This addition continues our focus on supporting breakthroughs in the cell therapy field with innovative bioprocessing solutions that allow for an easy transition from R&D to clinical manufacturing.”
Michiel Jannink, CEO of Scinus Cell Expansion, added, “We are really looking forward to working with Gemini Bio. Our products are very complementary and we both have the same mission: to bring the field of cell therapy further!”
Learn more at www.gembio.com.
About Gemini Bio
Founded in 1985, Gemini is a leading provider of cell culture solutions to the scientific community across cell and gene therapy, biotechnology, and academic research. Gemini also offers contract manufacturing and regulatory consulting services. Gemini’s singular mission is to enhance human life by delivering comprehensive cell culture solutions that enable discovery, development, and production of transformational therapies. Our national sales force and international distribution network serves cell culture science worldwide. The Company is based in West Sacramento, California.
Founded in 2004 (as part of Xpand biotechnology), Scinus Cell Expansion is a Dutch company which develops and distributes bioreactor technology for stem cell cultivation. Scinus’ mission is to make cell therapies accessible for a global patient population by means of developing an innovative bioreactor platform technology for the cell therapy industry. In addition to the development and marketing of bioreactor technology Scinus also offers process optimization and translation consulting services.